莲花健康(600186) - 2023 Q3 - 季度财报
LHGLHG(SH:600186)2023-10-15 16:00

Financial Performance - The company's operating revenue for Q3 2023 reached ¥640,697,808.71, representing a 40.98% increase compared to the same period last year[7]. - Net profit attributable to shareholders for Q3 2023 was ¥44,433,189.00, a significant increase of 162.82% year-on-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was ¥42,835,450.14, up 142.10% from the previous year[7]. - The basic earnings per share for Q3 2023 was ¥0.0248, reflecting a 163.50% increase compared to the same period last year[9]. - The weighted average return on equity for Q3 2023 was 3.01%, an increase of 1.81 percentage points year-on-year[9]. - Total operating revenue for the first three quarters of 2023 reached CNY 1,614,339,467.07, an increase of 22.8% compared to CNY 1,314,938,470.37 in the same period of 2022[35]. - Net profit for the third quarter of 2023 was CNY 96,843,503.27, compared to CNY 50,943,199.09 in the same quarter of 2022, representing an increase of 90.2%[40]. - Basic earnings per share for the third quarter of 2023 were CNY 0.0527, up from CNY 0.0272 in the same quarter of 2022, indicating a growth of 93.5%[44]. Assets and Liabilities - Total assets at the end of Q3 2023 amounted to ¥2,462,376,103.55, a 1.44% increase from the end of the previous year[9]. - The total assets as of September 30, 2023, amount to RMB 2,462,376,103.55, an increase from RMB 2,427,357,984.04 at the end of 2022[33]. - The total liabilities decreased to RMB 1,179,343,649.19 from RMB 1,229,721,338.29 year-over-year[33]. - Total liabilities as of the end of the reporting period were CNY 1,198,473,285.55, down from CNY 1,249,813,207.06 at the end of the previous year[35]. - The total equity attributable to shareholders of the parent company increased to CNY 1,496,581,966.45 from CNY 1,412,474,673.65, reflecting a growth of 5.9%[35]. Cash Flow - The company's cash flow from operating activities showed a decline of 44.87% year-to-date, totaling ¥76,409,887.00[9]. - Cash flow from operating activities for the first three quarters of 2023 was CNY 76,409,887.00, a decrease from CNY 138,595,957.36 in the same period of 2022[44]. - The company reported a net cash inflow from operating activities of CNY 1,843,964,602.73 for the first three quarters of 2023, compared to CNY 1,551,801,912.67 in the same period of 2022, an increase of 18.8%[44]. - Net cash flow from investing activities was -$43.82 million, compared to -$31.56 million in the previous period, indicating a decline of approximately 39%[45]. - Cash inflow from financing activities totaled $13.44 million, down from $20 million in the previous period, representing a decrease of about 33%[45]. - Cash outflow from financing activities was $30.47 million, compared to $35 million in the previous period, showing a reduction of approximately 13%[45]. - The net increase in cash and cash equivalents was $15.56 million, significantly lower than $92.04 million in the previous period, reflecting a decrease of around 83%[45]. - The ending balance of cash and cash equivalents was $615.46 million, down from $704.23 million in the previous period, indicating a decline of approximately 12.6%[45]. Expenses - Research and development expenses increased by 38.62% due to intensified efforts in new product development following the commissioning of new production facilities[17]. - The company reported a 45.21% increase in sales expenses, attributed to higher sales revenue and increased promotional costs for new products[17]. - Research and development expenses for the third quarter of 2023 amounted to CNY 14,240,968.98, compared to CNY 10,273,480.55 in the same quarter of 2022, marking an increase of 38.9%[38]. Shareholder Information - The total number of common shareholders as of September 30, 2023, is 68,353[25]. - The largest shareholder, Wuhu Lian Tai Investment Management Center, holds 180,509,529 shares, representing 10.06% of the total shares[25]. - The company has a repurchase account holding 19,381,400 shares, accounting for 1.08% of the total share capital[26]. - The company has no significant changes in its audit opinion type for the reporting period[27]. Inventory and Receivables - Accounts receivable increased to RMB 115,932,616.79 from RMB 102,852,835.07 year-over-year[29]. - Inventory has risen significantly to RMB 133,708,854.61 from RMB 74,211,106.40 compared to the previous year[29].